
Paltaz 4000mg/500mg Injection
Marketer
Palvin Pharmaceuticals
Salt Composition
Piperacillin (4000mg) + Tazobactum (500mg)
Overview Paltaz 4000mg/500mg Injection
Combiflox 4000mg/500mg Injection, a dual-antibiotic formulation, combats diverse bacterial infections by eliminating microorganisms. Administered solely by medical professionals, dosage and frequency are determined by your physician based on your condition's severity. Strict adherence to prescribed usage is crucial. Potential side effects include gastrointestinal upset (nausea, vomiting, diarrhea), skin rash, and injection site reactions (pain, swelling, redness). Persistent or worsening side effects necessitate immediate medical consultation. Prior to treatment, disclose any antibiotic allergies, kidney, or liver issues; your doctor may adjust the regimen accordingly. Generally considered safe for pregnant and breastfeeding individuals under medical guidance.
Uses of Paltaz 4000mg/500mg Injection
Infections caused by bacteria
Major Benefits of Paltaz 4000mg/500mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Paltaz 4000mg/500mg Injection:
- Nausea
- Vomiting
- Diarrhea
- Rash
- Allergic reaction
How to use Paltaz 4000mg/500mg Injection:
The medication will be administered by your physician or registered nurse; please refrain from self-medicating.
How Paltaz 4000mg/500mg Injection works:
The injectable formulation, Paltaz 4000mg/500mg, unites piperacillin, an antibiotic, with tazobactam, a beta-lactamase inhibitor. Piperacillin's mechanism involves disrupting bacterial cell wall synthesis, crucial for bacterial viability. Tazobactam counters bacterial resistance, thereby boosting piperacillin's antibacterial efficacy.
SAFETY ADVICE
AlcoholSAFE
Paltaz 4000mg/500mg Injection has no reported adverse interactions with alcohol consumption.
PregnancySAFE IF PRESCRIBED
The injectable formulation of Paltaz, 4000mg/500mg, is typically deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal or no harmful consequences to fetal development; nonetheless, data from human clinical trials remain scarce.
Breast feedingSAFE IF PRESCRIBED
The injectable formulation of Paltaz, 4000mg/500mg, presents minimal risk to breastfeeding infants. Research in humans indicates negligible transfer into breast milk, posing no apparent threat to the nursing child.
DrivingCONSULT YOUR DOCTOR
The impact of Paltaz 4000mg/500mg Injection on driving ability is undetermined. Refrain from operating a vehicle if you develop symptoms impairing concentration or reaction time.
KidneyCAUTION
For individuals with impaired kidney function, administration of Paltaz 4000mg/500mg Injection requires careful consideration. A modified dosage of Paltaz 4000mg/500mg Injection might be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
The use of Paltaz 4000mg/500mg Injection in individuals with hepatic impairment appears to pose minimal risk. Preliminary evidence indicates that dosage modification for Paltaz 4000mg/500mg Injection might be unnecessary in such cases. Physician consultation is recommended.
What if you forget to take Paltaz 4000mg/500mg Injection :
Should you forget a scheduled dose of Paltaz 4000mg/500mg Injection, seek advice from your physician.
Facts to Know About Paltaz 4000mg/500mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Antimicrobials |
